Biotechnology Stocks II Performance Guide: Pharming Group N.V. (PHAR)
PHAR has no dividends.
Table and Chart of PHAR Performance
See what a $1,000 investment in PHAR is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| PHAR Returns | |
|---|---|
| Start Date | Jan-29-2021 |
| Start Price | $14.30 |
| End Date | May-16-2024 |
| End Price | $9.55 |
| # Prices | 41 |
| Min Date | Jul-29-2022 |
| Min Price | $7.62 |
| Max Date | Jan-29-2021 |
| Max Price | $14.30 |
| Total Return | -33.22% |
| Annualized Return | -11.14% |
| Current Value of $1,000 Purchase | $668 |
| Number Returns | 820 |
| Average Return | 4.36% |
| Number Profitable Returns | 406 |
| Percent Profitable Returns | 49.51% |
| Number Unprofitable Returns | 414 |
| Percent Unprofitable Returns | 50.49% |
| Profitable to Unprofitable Returns Ratio | 0.98 |
| PHAR Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $645,490,000 |
| Beta | 0.735 | Price to Sales | 2.94 |
| Earnings per Share | $-0.1600 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 3.241 |
| PRICE DATA | |
| 52 Week High | $16.71 |
| 52 Week Low | $9.27 |
| Analyst Target Price | $None |
| 50-Day Moving Average | $10.5 |
| 200-Day Moving Average | $11.61 |
| FINANCIAL DATA | |
| Revenue per Share | $3.73 |
| Revenue | $245,316,000 |
| Profit Margin | -4.3% |
| Return on Equity | -4.98% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
PHAR Compare Returns with S&P 500
PHAR Trendline Chart
PHAR Moving Average Chart
PHAR Stock Return Map - See Patterns of Gains and Losses
PHAR Stock Returns/Purchase Dates